FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2150670605> ?p ?o ?g. }

• W2150670605 endingPage "538" @default.
• W2150670605 startingPage "529" @default.
• W2150670605 abstract "<h3>Background:</h3> Few comparative effectiveness studies of treatment strategies using antihypertensive therapeutic classes in hypertension control have been assessed in a primary care environment. The objectives are to compare the effectiveness of common antihypertensive therapeutic classes initiated as monotherapy and of fixed-dose combinations (FDCs), free-equivalent combinations (FECs), and monotherapy on hypertension control. <h3>Methods:</h3> This article reports observational comparative effectiveness analyses of data electronically extracted from electronic health records. The study population consisted of 8,676 patients with an incident prescription for an antihypertensive agent of a total of 79,176 patients receiving antihypertensive therapy in 33 geographically diverse primary care clinics. The main measures were reductions in systolic blood pressure (SBP) and diastolic blood pressure (DBP) and rates of attaining goals per the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC7). <h3>Results:</h3> There were small, clinically insignificant differences in blood pressure reductions between the monotherapy classes. Higher rates of blood pressure control were obtained when patients were initiated on an angiotensin-converting enzyme inhibitor than a thiazide or thiazide-like diuretic (47.8% vs 39.9%) or a β-blocker versus a thiazide (45.9% vs 39.9%). Patients initiated on FDCs had significantly larger reductions in blood pressure than patients initiated on FECs (−17.3 vs −12.0 mm Hg SBP; −10.1 vs −6.0 mm Hg DBP) or monotherapy (−17.3 vs −13.6 mm Hg SBP; −10.1 vs −7.9 mm Hg DBP). Rates of attaining JNC7 goals also were better for FDCs than FECs (57.2% vs 42.5%) and for FDCs versus monotherapy (57.2% vs 44.9%). <h3>Conclusions:</h3> Patients initiated on angiotensin-converting enzyme inhibitors and β-blockers had slightly higher rates of blood pressure control. The use of FDCs as initial therapy is more effective in the control of hypertension than monotherapy or FECs." @default.
• W2150670605 created "2016-06-24" @default.
• W2150670605 creator A5008330873 @default.
• W2150670605 creator A5016218720 @default.
• W2150670605 creator A5040269956 @default.
• W2150670605 creator A5075196716 @default.
• W2150670605 creator A5079674551 @default.
• W2150670605 date "2013-09-01" @default.
• W2150670605 modified "2023-10-02" @default.
• W2150670605 title "Comparative Effectiveness of Antihypertensive Therapeutic Classes and Treatment Strategies in the Initiation of Therapy in Primary Care Patients: A Distributed Ambulatory Research in Therapeutics Network (DARTNet) Study" @default.
• W2150670605 cites W1497461844 @default.
• W2150670605 cites W1590308968 @default.
• W2150670605 cites W1792264323 @default.
• W2150670605 cites W1981255881 @default.
• W2150670605 cites W1991085104 @default.
• W2150670605 cites W2019386940 @default.
• W2150670605 cites W2043244508 @default.
• W2150670605 cites W2046944571 @default.
• W2150670605 cites W2114229079 @default.
• W2150670605 cites W2122580076 @default.
• W2150670605 cites W2128616793 @default.
• W2150670605 cites W2131435758 @default.
• W2150670605 cites W2139480984 @default.
• W2150670605 cites W2143954917 @default.
• W2150670605 cites W2154628411 @default.
• W2150670605 cites W2155965977 @default.
• W2150670605 cites W2156121263 @default.
• W2150670605 cites W2160547085 @default.
• W2150670605 cites W2161490522 @default.
• W2150670605 cites W2318174853 @default.
• W2150670605 cites W2404212513 @default.
• W2150670605 cites W2410481992 @default.
• W2150670605 cites W75245760 @default.
• W2150670605 cites W2102354326 @default.
• W2150670605 cites W2145160336 @default.
• W2150670605 doi "https://doi.org/10.3122/jabfm.2013.05.130048" @default.
• W2150670605 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3918237" @default.
• W2150670605 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24004705" @default.
• W2150670605 hasPublicationYear "2013" @default.
• W2150670605 type Work @default.
• W2150670605 sameAs 2150670605 @default.
• W2150670605 citedByCount "37" @default.
• W2150670605 countsByYear W21506706052013 @default.
• W2150670605 countsByYear W21506706052014 @default.
• W2150670605 countsByYear W21506706052015 @default.
• W2150670605 countsByYear W21506706052016 @default.
• W2150670605 countsByYear W21506706052017 @default.
• W2150670605 countsByYear W21506706052018 @default.
• W2150670605 countsByYear W21506706052019 @default.
• W2150670605 countsByYear W21506706052020 @default.
• W2150670605 countsByYear W21506706052021 @default.
• W2150670605 countsByYear W21506706052022 @default.
• W2150670605 countsByYear W21506706052023 @default.
• W2150670605 crossrefType "journal-article" @default.
• W2150670605 hasAuthorship W2150670605A5008330873 @default.
• W2150670605 hasAuthorship W2150670605A5016218720 @default.
• W2150670605 hasAuthorship W2150670605A5040269956 @default.
• W2150670605 hasAuthorship W2150670605A5075196716 @default.
• W2150670605 hasAuthorship W2150670605A5079674551 @default.
• W2150670605 hasBestOaLocation W21506706051 @default.
• W2150670605 hasConcept C126322002 @default.
• W2150670605 hasConcept C149323552 @default.
• W2150670605 hasConcept C2426938 @default.
• W2150670605 hasConcept C2776999253 @default.
• W2150670605 hasConcept C2779918671 @default.
• W2150670605 hasConcept C2780361556 @default.
• W2150670605 hasConcept C2780437262 @default.
• W2150670605 hasConcept C2908647359 @default.
• W2150670605 hasConcept C35785553 @default.
• W2150670605 hasConcept C71924100 @default.
• W2150670605 hasConcept C84393581 @default.
• W2150670605 hasConcept C98274493 @default.
• W2150670605 hasConcept C99454951 @default.
• W2150670605 hasConceptScore W2150670605C126322002 @default.
• W2150670605 hasConceptScore W2150670605C149323552 @default.
• W2150670605 hasConceptScore W2150670605C2426938 @default.
• W2150670605 hasConceptScore W2150670605C2776999253 @default.
• W2150670605 hasConceptScore W2150670605C2779918671 @default.
• W2150670605 hasConceptScore W2150670605C2780361556 @default.
• W2150670605 hasConceptScore W2150670605C2780437262 @default.
• W2150670605 hasConceptScore W2150670605C2908647359 @default.
• W2150670605 hasConceptScore W2150670605C35785553 @default.
• W2150670605 hasConceptScore W2150670605C71924100 @default.
• W2150670605 hasConceptScore W2150670605C84393581 @default.
• W2150670605 hasConceptScore W2150670605C98274493 @default.
• W2150670605 hasConceptScore W2150670605C99454951 @default.
• W2150670605 hasIssue "5" @default.
• W2150670605 hasLocation W21506706051 @default.
• W2150670605 hasLocation W21506706052 @default.
• W2150670605 hasLocation W21506706053 @default.
• W2150670605 hasOpenAccess W2150670605 @default.
• W2150670605 hasPrimaryLocation W21506706051 @default.
• W2150670605 hasRelatedWork W1572563556 @default.
• W2150670605 hasRelatedWork W2008785082 @default.
• W2150670605 hasRelatedWork W2013544372 @default.
• W2150670605 hasRelatedWork W2125431201 @default.
• W2150670605 hasRelatedWork W2351940717 @default.
• W2150670605 hasRelatedWork W2401948839 @default.

• next